LGND - CIK 0000886163
LIGAND PHARMACEUTICALS INC has filed 2,226 documents with the SEC between 1994 and 2026. The most frequent type is insider trade (886 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Proxy materials | DEFA14A | 2026-05-18 | - |
| Major company event | 8-K | 2026-05-18 | 2026-05-16 |
| Insider trade | 4 | 2026-05-14 | 2026-05-01 |
| Insider sale notice | 144 | 2026-05-13 | - |
| Insider sale notice | 144 | 2026-05-12 | - |
| Quarterly report | 10-Q | 2026-05-08 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Insider trade | 4 | 2026-05-04 | 2026-05-01 |
| SCHEDULE 13G | - | 2026-05-01 | - |
| SCHEDULE 13G | - | 2026-05-01 | - |
| Insider sale notice | 144 | 2026-05-01 | - |
| SCHEDULE 13D | - | 2026-05-01 | - |
| Major company event | 8-K | 2026-04-30 | 2026-04-24 |
| Proxy materials | DEFA14A | 2026-04-28 | - |
| Proxy materials | DEFA14A | 2026-04-27 | - |
| Major company event | 8-K | 2026-04-27 | 2026-04-27 |
| Annual report to shareholders | ARS | 2026-04-21 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-21 | - |
| Proxy statement | DEF 14A | 2026-04-21 | 2025-12-31 |
| Insider trade | 4 | 2026-04-02 | 2026-04-01 |
| Insider trade | 4 | 2026-04-02 | 2026-04-01 |
| Insider sale notice | 144 | 2026-04-01 | - |
| Insider trade | 4 | 2026-03-31 | 2026-03-06 |
| Insider trade | 4 | 2026-03-27 | 2026-03-02 |
| Insider trade | 4 | 2026-03-27 | 2026-03-02 |
| Insider trade | 4 | 2026-03-27 | 2026-03-02 |
| SCHEDULE 13G/A | - | 2026-03-27 | - |
| Insider trade | 4 | 2026-03-25 | 2026-03-23 |
| Insider sale notice | 144 | 2026-03-23 | - |
| Insider trade | 4 | 2026-03-13 | 2026-03-11 |
| Insider sale notice | 144 | 2026-03-11 | - |
| Insider trade | 4 | 2026-03-06 | 2026-03-04 |
| Insider trade | 4 | 2026-03-06 | 2026-03-04 |
| Insider sale notice | 144 | 2026-03-06 | - |
| Insider trade | 4 | 2026-03-05 | 2026-03-03 |
| Insider trade | 4 | 2026-03-04 | 2026-03-02 |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-04 | - |
| Insider sale notice | 144 | 2026-03-03 | - |
| S-3ASR | - | 2026-02-27 | - |
| Annual report | 10-K | 2026-02-27 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| Insider trade | 4 | 2026-02-18 | 2026-02-14 |
| Insider trade | 4 | 2026-02-18 | 2026-02-14 |
| Insider trade | 4 | 2026-02-18 | 2026-02-14 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider sale notice | 144 | 2026-02-02 | - |
| Insider trade | 4 | 2026-01-06 | 2026-01-02 |
| Insider trade | 4 | 2026-01-06 | 2025-12-31 |
| Insider sale notice | 144 | 2026-01-02 | - |